Community Board
Investment Case · Oct 7, 2026
Active
2

$JPM

LONG
JP Morgan Chase & Co. · NYSE
Franchise Earnings Power at 14x Earnings
RResearch Desk @research_desk Editorial Verified25 cases · 17% hit · -0.8% avgConviction 3/5 Into Q4 2026 earnings (Jan 2027), with a 12 month view
Thesis

JPM is compounding revenue across NII, investment banking and markets while card credit costs improve, and it holds excess capital to return. At roughly 14x trailing earnings, the shares sit about 10% below the Street's average target and below the August high.

Performance Since Publication
In the thesis direction
Return
+2.4%
At Publication
$331.28
Last
$339.30
To Target
+7.0%
STOP$315.00AT PUBLICATION$331.28PRICE TARGET$363.00LAST$339.30
Company Snapshot
JPMorgan Chase & Co.
National Commercial Banks
Mega Cap
Market Cap
$901.0B
P/E (TTM)
—
Dividend Yield
—
Beta
—
Avg Volume
—
200-Day Avg
—
Next Earnings
—
Employees
320.6K

JPMorgan Chase is a leading global financial-services firm with operations in 66 countries and nearly 323,000 employees as of September 2026. Under the JPMorgan brands, the bank holding company boasts a $5.1 trillion balance sheet and $2.78 trillion in deposits as of September 2026. The firm generates its revenue across three core operating segments:…

www.jpmorganchase.com
Price Levels
Entry
$325.00
Price Target
$363.00
Stop
$315.00
Catalysts
  1. 1Q3 earnings on Oct 13, 2026: consensus is about $5.86 to $5.89 EPS on about $50.8B to $50.9B revenue, so watch IB fees and NII guidance.
  2. 2FY26 guidance updates at Q3 and the Q4 print (expected mid-January 2027, unconfirmed), especially NII ex-Markets and the card charge-off rate.
  3. 3Any Fed easing or a deployment of the excess capital through buybacks or acquisitions.
Key Risks
  1. 1Q2 may be a cyclical peak: equity markets revenue rose 86% and could normalize, and the bank flagged this as an elevated environment.
  2. 2Expenses are rising faster than revenue: Q2 adjusted expense was up 15%, and management acknowledged negative operating leverage year to date.
  3. 3No Fed cuts and sticky inflation (Iran war, energy prices) could pressure credit and loan demand later in a maturing cycle.
Read the Full Thesis
The market is treating Q2 as a peak: CEO Dimon called the environment as good as it gets, and the stock is about 10% below its August high. The long case is that earnings power is broader than trading. Q2 investment banking fees rose 30% to $3.3B, the highest since 2021, and every line of business posted record revenue (per Q2 2026 release and Yahoo Finance). Management raised FY26 NII guidance to about $105.5B and cut the card charge-off guide to about 3.2% (per Hudson Labs summary of Q2 guidance). That is a better revenue and credit mix than the stock's multiple implies. On rates, the NII story does not need Fed cuts. NII ex-Markets was up 4% in Q2 even with lower rates, helped by deposit and loan growth. JPM's own economist forecast no 2026 cuts (per Yahoo Finance), so any easing is upside, not a requirement. Capital is a cushion. Standardized CET1 was 14.1% at Q2 (per Q2 call), and Hudson Labs cites more than $40B of excess capital. The shares trade at about 14x trailing EPS (per Robinhood), and the average analyst target is $363 (per MarketBeat). For the case to hold, IB and markets revenue must stay near current levels, card losses must keep improving, and expense growth must not outrun revenue.
Updates Since Publication
  1. Oct 13, 2026 · Price 333.92

    Weekly check-in: Weakened. Q3 miss and halved buyback dent capital leg; NII and card credit hold Per the Q3 release, EPS was $5.57 (about $5.75 excluding a $658M securities loss) against consensus of roughly $5.86 to $5.94. Managed revenue was $50.9B, in line with the case's $50.8B to $50.9B, but reported revenue was $50.2B. The NII and card-credit legs held up: the FY26 NII guide rose and the card charge-off guide stayed near 3.2%. Two other legs weakened. Expenses grew 12% against revenue growth of 8%, and management cut buybacks to prioritize organic growth, which undercuts the idea that excess capital is a cushion to return.

  2. Oct 20, 2026 · Price 338.17

    Weekly check-in: Weakened. Street trims JPM targets after Q3 miss; thesis legs unchanged since last check Little new has arrived since the Oct 13 print. What did arrive leans slightly negative for the capital and valuation legs, and the NII and card legs still hold. Per Yahoo Finance, Citigroup cut its target from $360 to $350 on Oct 15, and Investing.com reported Phillip Securities also lowered its target on an earnings cut. The shares have recovered to about $338, roughly 3% above the pre-earnings close of $334.30, so the post-miss price action has not added a new problem.

The Other Side

Disagree? Make the opposite case with your own levels. Both get scored, so the debate gets a winner.

Track This Case

Copy it into your own account, adjust it to your view, and get an alert when the price reaches its levels.

Discussion
Do You Agree With @research_desk?
agreedisagree
No one has weighed in yet. Be the first. A stance is a reader's view, not advice.
Be specific and civil. No promotion or price-pumping. Comments are checked before they appear. Guidelines

No comments yet. Start the discussion with the point you'd want the author to answer.

Investment case published by @research_desk. It reflects the author’s own views at the time of publication and is for information only. It is not investment advice or a recommendation to buy or sell any security. Prices and company data are delayed and may be inaccurate. User content is not verified. Editorial cases are written by our research desk with AI research assistance and reviewed by the team. · How we measure performance

Long $JPM | Investment Case. JPM is compounding revenue across NII, investment banking and markets while card credit costs improve, and it holds excess capital to return. At roughly 14x trailing earnings, t…